ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2459

Effect of Obesity and Surgical Weight Loss on Joint Surgery Hospitalizations in Psoriatic Arthritis: Data from National Inpatient Sample

Rashmi Dhital1, Dilli Ram Poudel 2, Anthony Donato 3, Olubunmi Oladunjoye 4 and Paras Karmacharya 5, 1Reading Hospital ,PA, Shillington, PA, 2University of Pennsylvania, Philadelphia, 3Reading Hospital, PA, Reading, 4Reading Hospital, PA, West Reading, PA, 5Reading Hospital, Mayo Clinic, Rochester

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: bariatric and psoriatic arthritis, obesity

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 12, 2019

Title: Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster III: Psoriatic Arthritis, Clinical Features

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Obesity is associated with higher disease activity and poor treatment response in patients with psoriatic arthritis (PsA). However, there is limited data as to how weight loss strategies affect outcomes in PsA. The aim of our study was to compare joint surgery hospitalizations (as a surrogate marker of significant radiographic damage and progression) among (1) obese and non-obese PsA patients; (2) obese PsA patients without and with a history of bariatric procedure and subsequent weight loss.

Methods: National Inpatient Sample (2001-2014) was used to identify patients ≥ 18 years with PsA using ICD-9 code 696.0.  To increase the specificity, we excluded patients with RA (ICD-9 code 714.0) and AS (ICD-9 code 720.0) (Figure 1). For each patient with PsA, a matched control of the same age (± 1 year), sex, race/ethnicity and NIS stratum (based on hospital’s census region or division, ownership/control, location/teaching, and bed size) was randomly selected.  We compared hospitalizations for joint surgeries among obese and non-obese PsA patients. Joint surgeries related to trauma/fracture were excluded. Secondly, we performed univariate and multivariate regression to compare joint surgery hospitalizations among PsA patients with a history of bariatric procedure vs. those without bariatric procedure. For this analysis, hospitalizations prior to 2006 were excluded as the ICD-9 code for history of bariatric procedure (V45.86) did not exist.  Patients with current hospitalization for bariatric surgery were excluded to avoid confounding in the time gap between surgery and weight loss. Patients with a diagnosis of obesity were excluded from the group with a history of bariatric procedure in order to identify post-bypass patients who were no longer obese.

Results: In 2001-2014, there were 266,096 PsA hospitalizations. Among them, 44,055 (16.6 %) PsA patients had obesity or morbid obesity compared to 11.6% in the general population (p < 0.001). The overall hospitalization for joint surgeries in PsA was 7.42%. The rates of joint surgeries were significantly different among obese versus non-obese PsA hospitalizations (9.55 % vs 7.0%, p< 0.001) (Table 1). Mean age of joint surgery was 59.68 ± 9.42 years vs. 62.13± 10.83 years (p< 0.001) in obese PsA compared to non-obese PsA patients (Table 1). In the years 2006-2014, a total of 1,640 (0.91%) PsA hospitalizations had a history of bariatric surgery with no current diagnosis of obesity. There was no significant difference in overall joint surgery hospitalizations among these surgically treated formerly obese patients compared to currently obese PsA patients with no history of bariatric surgery (OR 0.83, 95% CI 0.54 – 1.27, p=0.4)(Table 2).

Conclusion: Our study showed obese PsA patients had higher hospitalizations for joint surgeries compared to non-obese patients. However, no difference was noted in joint surgery hospitalizations among PsA patients without and with a history of bariatric procedure and not currently obese. While few studies have shown improvement in disease activity after weight loss, the benefit of weight loss might be more in early PsA. Further longitudinal studies should explore the short and long-term effect of weight loss on PsA disease outcomes.

Figure 1. Flow chart showing the selection of PsA patients with joint surgery hospitalizations

Table 1- Hospitalizations for joint surgery in obese and non-obese psoriatic arthritis patients -2001-2014-

Table 2- Univariate and multivariate regression analyses of risk of joint surgery hospitalizations in patients with psoriatic arthritis treated with bariatric surgery -2006-2014-
*** Multivariate analysis adjusted for age, gender, insurance status, hypertension, diabetes mellitus, dyslipidemia, current smoking status, hospitalization year and NIS stratum


Disclosure: R. Dhital, None; D. Poudel, None; A. Donato, None; O. Oladunjoye, None; P. Karmacharya, None.

To cite this abstract in AMA style:

Dhital R, Poudel D, Donato A, Oladunjoye O, Karmacharya P. Effect of Obesity and Surgical Weight Loss on Joint Surgery Hospitalizations in Psoriatic Arthritis: Data from National Inpatient Sample [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/effect-of-obesity-and-surgical-weight-loss-on-joint-surgery-hospitalizations-in-psoriatic-arthritis-data-from-national-inpatient-sample/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/effect-of-obesity-and-surgical-weight-loss-on-joint-surgery-hospitalizations-in-psoriatic-arthritis-data-from-national-inpatient-sample/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology